Group One Trading
SRPT icon

Group One Trading’s Sarepta Therapeutics SRPT Stock Holding History

Group One Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6M Sell
487,500
-151,800
-24% -$2.94M 0.02% 809
2025
Q4 		$13.8M Sell
639,300
-40,300
-6% -$849K 0.02% 751
2025
Q3 		$13.1M Buy
679,600
+449,400
+195% +$8.01M 0.02% 740
2025
Q2 		$3.94M Buy
230,200
+84,500
+58% +$3.61M 0.01% 1515
2025
Q1 		$9.3M Sell
145,700
-57,500
-28% -$6.05M 0.03% 659
2024
Q4 		$24.7M Buy
203,200
+25,400
+14% +$3.11M 0.06% 301
2024
Q3 		$22.2M Buy
177,800
+31,300
+21% +$4.33M 0.06% 249
2024
Q2 		$23.1M Buy
146,500
+15,000
+11% +$1.93M 0.09% 162
2024
Q1 		$17M Sell
131,500
-166,900
-56% -$20.4M 0.07% 235
2023
Q4 		$28.8M Sell
298,400
-78,200
-21% -$7.5M 0.08% 213
2023
Q3 		$45.7M Buy
376,600
+5,700
+2% +$644K 0.15% 80
2023
Q2 		$42.5M Buy
370,900
+207,100
+126% +$26.7M 0.14% 84
2023
Q1 		$22.6M Buy
163,800
+48,600
+42% +$6.3M 0.08% 186
2022
Q4 		$14.9M Buy
115,200
+41,700
+57% +$4.83M 0.03% 522
2022
Q3 		$8.13M Buy
73,500
+5,600
+8% +$564K 0.02% 846
2022
Q2 		$5.09M Sell
67,900
-5,600
-8% -$412K 0.01% 1277
2022
Q1 		$5.74M Sell
73,500
-28,800
-28% -$2.21M 0.01% 1442
2021
Q4 		$9.21M Buy
102,300
+11,800
+13% +$1.01M 0.01% 1169
2021
Q3 		$8.37M Sell
90,500
-7,400
-8% -$570K 0.01% 1212
2021
Q2 		$7.61M Sell
97,900
-115,100
-54% -$8.73M 0.01% 1310
2021
Q1 		$15.9M Buy
213,000
+29,400
+16% +$2.71M 0.02% 663
2020
Q4 		$31.3M Buy
183,600
+32,000
+21% +$4.74M 0.05% 298
2020
Q3 		$21.3M Buy
151,600
+56,600
+60% +$8.6M 0.07% 258
2020
Q2 		$15.2M Sell
95,000
-37,000
-28% -$5.04M 0.07% 306
2020
Q1 		$12.9M Sell
132,000
-104,600
-44% -$12M 0.1% 181
2019
Q4 		$30.5M Buy
236,600
+31,900
+16% +$3.22M 0.21% 72
2019
Q3 		$15.4M Buy
204,700
+14,700
+8% +$1.74M 0.12% 160
2019
Q2 		$28.9M Buy
190,000
+74,000
+64% +$8.99M 0.26% 49
2019
Q1 		$13.8M Buy
116,000
+4,100
+4% +$527K 0.15% 117
2018
Q4 		$12.2M Sell
111,900
-1,200
-1% -$150K 0.11% 188
2018
Q3 		$18.3M Buy
113,100
+2,000
+2% +$273K 0.14% 129
2018
Q2 		$14.7M Buy
111,100
+53,900
+94% +$5.08M 0.13% 160
2018
Q1 		$4.24M Sell
57,200
-88,100
-61% -$5.87M 0.04% 558
2017
Q4 		$8.08M Sell
145,300
-414,200
-74% -$21.9M 0.06% 416
2017
Q3 		$25.4M Buy
559,500
+471,800
+538% +$18.9M 0.23% 74
2017
Q2 		$2.96M Sell
87,700
-76,300
-47% -$2.48M 0.03% 728
2017
Q1 		$4.85M Sell
164,000
-503,000
-75% -$15.6M 0.06% 412
2016
Q4 		$18.3M Sell
667,000
-336,100
-34% -$13.5M 0.18% 106
2016
Q3 		$61.6M Sell
1,003,100
-245,500
-20% -$7.42M 0.67% 13
2016
Q2 		$23.8M Buy
1,248,600
+1,037,600
+492% +$19.2M 0.28% 54
2016
Q1 		$4.12M Sell
211,000
-27,900
-12% -$487K 0.06% 416
2015
Q4 		$9.22M Sell
238,900
-160,300
-40% -$5.2M 0.11% 186
2015
Q3 		$12.8M Buy
399,200
+162,200
+68% +$5.5M 0.18% 102
2015
Q2 		$7.21M Buy
237,000
+109,100
+85% +$2.23M 0.1% 216
2015
Q1 		$1.7M Sell
127,900
-224,900
-64% -$3M 0.03% 732
2014
Q4 		$5.11M Buy
352,800
+53,500
+18% +$906K 0.08% 281
2014
Q3 		$6.32M Sell
299,300
-56,300
-16% -$1.27M 0.1% 223
2014
Q2 		$10.6M Sell
355,600
-14,600
-4% -$461K 0.16% 112
2014
Q1 		$8.9M Buy
370,200
+2,100
+0.6% +$53.5K 0.15% 116
2013
Q4 		$7.5M Buy
368,100
+43,400
+13% +$1.29M 0.11% 163
2013
Q3 		$15.3M Buy
324,700
+114,300
+54% +$4.4M 0.29% 49
2013
Q2 		$8.01M Buy
+210,400
New +$7.52M 0.2% 93

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's SRPT Position: Q1 2026 in Review

Group One Trading reduced its Sarepta Therapeutics (SRPT) stake by 29% in Q1 2026, selling an estimated $791K and leaving 99,915 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Group One Trading first reported a position in SRPT in Q2 2013 and has held it in 41 quarters since. The position peaked at $27.8M in Q1 2023. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Group One Trading held 99,915 shares of Sarepta Therapeutics worth $2.17M as of Q1 2026.
  • Group One Trading sold 40,859 Sarepta Therapeutics shares in Q1 2026, an estimated $791K.
  • Sarepta Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #1996 holding.
  • Group One Trading first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 41 quarters since.
  • Group One Trading's Sarepta Therapeutics position peaked at $27.8M in Q1 2023.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.